{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:55:56Z","timestamp":1791021356414,"version":"4.1.0"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  BACKGROUND: Helicobacter pylori infection in Chile remains as a public and private health-care system\u2019s challenge, with a prevalence of the infection over 70%. Nowadays, antibiotic treatment of the infection is mandatory to prevent the arising of severe associated diseases but failures in the eradication therapy mainly due to clarithromycin resistance has been observed worldwide and first line eradication therapy seems to be not effective anymore in several geographical areas. Thus, health-care systems are committed to maintain an epidemiological surveillance upon the evolution of the antibiotic resistance of this priority 2 pathogen.  OBJECTIVE:  This work reports a 10 years surveillance of the primary antibiotic resistance of H. pylori clinical isolates at the Biob\u00edo region-Chile, and the evolution of resistance toward amoxicillin, clarithromycin, levofloxacin, metronidazole, and tetracycline among the species.  METHODS: H. pylori strains were investigated during the periods 2005-2007 (1435 patients analysed) and 2015-2017 (220 patients analysed) by inoculating a saline homogenate biopsy onto the surface of Columbia agar (Oxoid, Basingstoke, UK) - supplemented with 7% horse red blood cells plus DENT inhibitor (Oxoid, Basingstoke, UK) - following by incubation at 37\u00baC under 10% CO2 atmosphere for five days. Antibiotic resistance pattern of the isolates was assessed using the disk diffusion test in M\u00fceller-Hinton agar supplemented with 7% horse red blood cells followed by incubation for further three days under 10% CO2 atmosphere. Statistical analysis was done using the SPSS v22 software and P values &lt;0.05 were considered statistically significant.  RESULTS:  A total of 41% of 1435 patients were detected to be infected with H. pylori by bacteriological culture in 2005-2007 period, meanwhile 32.7% from 220 patients were also infected in 2015-2017 period. The clinical isolates of H. pylori are mostly susceptible to amoxicillin and tetracycline (both over 98% of strains), but less susceptible to levofloxacin in both periods analysed (over 79% of the strains). On the other hand, metronidazole continuous showing the highest score of resistant isolates (over 40% of resistant strains), although an 18% fewer resistant strains were observed in 2015-2017 period. Clarithromycin, the key antibiotic in eradication therapies, has an increased frequency of resistant strain isolated in the decade (22.5% in 2005-2007 and 29.2% in 2015-2017). Multidrug resistant strains (two, three and four antibiotics) were also detected in both periods with the highest scores for simultaneous resistance to clarithromycin-metronidazole (18%) and clarithromycin-metronidazole-levofloxacin (12.5%) resistant strains. According to gender, the isolates resistant to amoxicillin, clarithromycin and metronidazole were more frequent in female, with a specific increment in amoxicillin and clarithromycin resistance.  CONCLUSION:  The frequency of clarithromycin resistance (29.2%) detected in 2015-2017 suggests that conventional triple therapy is no longer effective in this region.<\/jats:p>","DOI":"10.1590\/s0004-2803.201900000-72","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:33:25Z","timestamp":1573068805000},"page":"361-366","source":"Crossref","is-referenced-by-count":20,"title":["ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOB\u00cdO REGION (CHILE) IN A DECADE"],"prefix":"10.1590","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9836-8107","authenticated-orcid":false,"given":"Cristian","family":"PARRA-SEP\u00daLVEDA","sequence":"first","affiliation":[{"name":"Universidad de Concepci\u00f3n,  Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-5786","authenticated-orcid":false,"given":"Jos\u00e9 S","family":"MERINO","sequence":"additional","affiliation":[{"name":"Universidad de las Am\u00e9ricas,  Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-8038","authenticated-orcid":false,"given":"Katia","family":"S\u00c1EZ-CARRILLO","sequence":"additional","affiliation":[{"name":"Universidad de Concepci\u00f3n,  Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-5586","authenticated-orcid":false,"given":"Carlos","family":"GONZ\u00c1LEZ","sequence":"additional","affiliation":[{"name":"Universidad de Concepci\u00f3n,  Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3909-9733","authenticated-orcid":false,"given":"Apolinaria","family":"GARC\u00cdA-CANCINO","sequence":"additional","affiliation":[{"name":"Universidad de Concepci\u00f3n,  Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Camargo MC","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/1055-9965.EPI-06-0514","article-title":"Gastric cancer is related to early Helicobacter pylori infection in a high-prevalence country","volume":"16","author":"Ferreccio C","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10552-012-0117-5","article-title":"Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)","volume":"24","author":"Porras C","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref4","series-title":"Tratamiento de erradicaci\u00f3n de Helicobacter pylori en el paciente con ulcera p\u00e9ptica","first-page":"1","year":"2013"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.eimc.2018.03.016","article-title":"Din\u00e1mica de la infecci\u00f3n por Helicobacter pylori en lactantes durante los primeros seis meses de vida","volume":"37","author":"Merino JS","year":"2019","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection-the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner P","year":"2012","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner P","year":"2017","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QCO.0000000000000396","article-title":"Antibiotic resistance in Helicobacter pylori","volume":"30","author":"Alba C","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli E","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000001257","article-title":"Helicobacter pylori-clarithromycin resistance in symptomatic paediatric patients in a High Prevalence Country","volume":"64","author":"Serrano CA","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref11","first-page":"132","article-title":"Usefulness of culture, histology, and urease testing in detection of C. pyloridis","volume":"84","author":"Schnell G","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijantimicag.2004.07.009","article-title":"Comparison of E-Test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica","volume":"24","author":"Lang L","year":"2004","journal-title":"Int J Antimicrob Ag"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JCM.37.5.1628-1631.1999","article-title":"Assessment of metronidazole susceptibility in Helicobacter pylori: Statistical validation and error rate analysis of breakpoints determined by disk diffusion test","volume":"37","author":"Chaves S","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref14","first-page":"11","article-title":"Resistencia antibi\u00f3tica del Helicobacter pylori en el Hospital Universitario San Ignacio de Bogot\u00e1","volume":"33","author":"Yepes CA","year":"2008","journal-title":"Acta M\u00e9d Colomb"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1128\/JCM.31.7.1924-1926.1993","article-title":"Levofloxacin disk potency and interpretative criteria for susceptibility tests","volume":"31","author":"Pfaller MA","year":"1993","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1523-5378.2011.00820.x","article-title":"Levofloxacin susceptibility testing for Helicobacter pylori in China: Comparison of E\u2010Test and disk diffusion method","volume":"16","author":"Yu C","year":"2011","journal-title":"Helicobacter"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4067\/S0034-98872001000600007","article-title":"Susceptibilidad in vitro de cepas de Helicobacter pylori: aislamiento de cepas resistentes a claritromicina","volume":"129","author":"Gonz\u00e1lez CC","year":"2001","journal-title":"Rev M\u00e9d Chile"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/JCM.34.5.1232-1234.1996","article-title":"Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format","volume":"34","author":"V\u00e1squez A","year":"1996","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1590\/S1517-83822011000200005","article-title":"Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern Chile","volume":"42","author":"Otth L","year":"2011","journal-title":"Braz J Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12876-018-0820-0","article-title":"Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa","volume":"18","author":"Gonzalez-Hormazabal P","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12866-019-1517-4","article-title":"The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer","volume":"19","author":"Dan W","year":"2019","journal-title":"BMC Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000226426","article-title":"In vitro Antagonism of Rabeprazole and Metronidazole upon Clinical Isolates of Helicobacter pylori","volume":"55","author":"Soto A","year":"2009","journal-title":"Chemother"},{"key":"ref23","first-page":"153","article-title":"Sensibilidad a los antimicrobianos de aislamientos de Helicobacter pylori aislados de lesiones g\u00e1stricas","volume":"49","author":"Pereyra LV","year":"2017","journal-title":"Rev Argent Microbiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1590\/S1517-83822014000400039","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: Comparing agar dilution, E-test, and disk diffusion","volume":"45","author":"Ogata S","year":"2014","journal-title":"Braz J Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/00365521.2015.1092577","article-title":"In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy","volume":"51","author":"Di Giulio M","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cmi.2016.06.003","article-title":"Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods","volume":"22","author":"Ducournau A","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.diagmicrobio.2015.09.011","article-title":"Levofloxacin susceptibility testing against Helicobacter pylori: evaluation of a modified disk diffusion method compared to E test","volume":"84","author":"Boyanova L","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref28","article-title":"Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics","author":"Fallone C","year":"2019","journal-title":"Gastroenterology"},{"key":"ref29","series-title":"Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics","year":"2019"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein EY","year":"2018","journal-title":"PNAS"},{"key":"ref31","first-page":"627","article-title":"Variabilidad de la prescripci\u00f3n de antibi\u00f3ticos en atenci\u00f3n primaria de los sectores sanitarios de Arag\u00f3n","volume":"86","author":"Lallana MJ","year":"2012","journal-title":"Revista Espa\u00f1ola de Salud P\u00fablica"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.aprim.2010.04.015","article-title":"Alta exposici\u00f3n a antibi\u00f3ticos en la poblaci\u00f3n y sus diferencias por g\u00e9nero y edad","volume":"43","author":"Serna MC","year":"2011","journal-title":"Atenci\u00f3n Primaria"},{"key":"ref33","first-page":"75","article-title":"Avances recientes en el tratamiento de la infecci\u00f3n por Helicobacter pylori","volume":"47","author":"Molina-Infante J","year":"2017","journal-title":"Acta Gastroenterol Latinoam"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v56n4\/1678-4219-ag-s0004280320190000072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T21:19:32Z","timestamp":1596230372000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032019000400361&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["S0004-28032019000400361"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.201900000-72","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}